Pfizer Inc. News
Novavax Stock Slides As JPMorgan Slashes Price Target, Lowers Rating
JPMorgan analyst Eric Joseph slashed his price target on Novavax by more than $100, to $27 per share.
Goldman Sachs Lists Most Underweighted Value Stocks
Value stocks will gain whether inflation peaks or the Fed tightens enough to spark a recession, Goldman Sachs said.
Exact Sciences: Don't Deem It Guilty by Association
Genetic-testing stocks, especially those championed by asset manager Cathie Wood, have been pummeled. It's important to differentiate.
Biosimilars Are Saving America $1 Billion Per Month
Competitive drug prices are great for consumers. Turns out, they're good for industry, too.
Moderna Sues Pfizer, BioNtech For Covid Vaccine Patent Infringement
"We believe that Pfizer and BioNTech unlawfully copied Moderna's inventions, and they have continued to use them without permission," Moderna said.
Pfizer Stock Slumps Amid Litigation Concerns Linked to Zantac Heartburn Drug
Zantac, also sold as ranitidine, was pulled from the market in 2020 following a study that suggested it contained a cancer-causing impurity.
Stock Market Today - 8/11: Stocks End Mixed As Cooling Inflation Slows Fed Rate Bets
Stocks finished the day mixed as investors reappraised inflation concerns and the potential impact on interest rates.
Biogen Stock Clings to Key Level After Explosive Rally
Biogen stock is up almost 40% on Wednesday but is barely holding above a key level. Let's look at the chart.
Americans Heavily Favor Hiring Ex-Cons for Open Jobs
Fully 89% of Americans say ex-offenders should be given a second chance, a survey says.
LeBron James Buying a Piece of a Major League Team
Participation in this sport grew the fastest of any in the U.S. from 2019-21, reaching the 4.8 million-player mark.
DocuSign Stock Jumps On Job Cut Plan Ahead Of New CEO Allan Thygesen
DocuSign said the job cuts will "improve operating margin and support the company’s growth, scale and profitability objectives".